TR-571

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameTR-571
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsThalassemiaAnemia, Sickle CellAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTranscend Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranscend Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsThalassemiaAnemia, Sickle CellAnemia

Other Information

ATC CodeN/A
Related LinksN/A